Akums Drugs and Pharmaceuticals has informed that it enclosed the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2025, issued by, Kavita, Partner of A. K. Nandwani & Associates, the Secretarial Auditor of the Company.
The above information is a part of company’s filings submitted to BSE.